Gene: RAB3GAP1
Official Full Name: RAB3 GTPase activating protein catalytic subunit 1provided by HGNC
Gene Summary: This gene encodes the catalytic subunit of a Rab GTPase activating protein. The encoded protein forms a heterodimer with a non-catalytic subunit to specifically regulate the activity of members of the Rab3 subfamily of small G proteins. This protein mediates the hydrolysis of GTP bound Rab3 to the GDP bound form. Mutations in this gene are associated with Warburg micro syndrome. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Feb 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30109 | RAB3GAP1 Knockout cell line (HeLa) | Human | RAB3GAP1 | 1:3~1:6 | Negative | Online Inquiry |
KO30110 | RAB3GAP1 Knockout cell line (HCT 116) | Human | RAB3GAP1 | 1:2~1:4 | Negative | Online Inquiry |
KO30111 | RAB3GAP1 Knockout cell line (HEK293) | Human | RAB3GAP1 | 1:3~1:6 | Negative | Online Inquiry |
KO30112 | RAB3GAP1 Knockout cell line (A549) | Human | RAB3GAP1 | 1:3~1:4 | Negative | Online Inquiry |
RAB3GAP1 Gene Knockout Cell Lines are engineered cellular systems in which the RAB3GAP1 gene has been specifically disrupted, providing a powerful tool for studying the implications of this gene in various biological processes. RAB3GAP1 encodes a protein that plays a crucial role in the regulation of synaptic vesicle release, impacting neurotransmission and neuronal communication. By creating knockout models, researchers can investigate the functional consequences of RAB3GAP1 deficiency, particularly in neurological disorders and synaptic transmission abnormalities.
The key mechanism underlying these knockout cell lines is the selective abrogation of RAB3GAP1 expression, achieved through CRISPR-Cas9 gene editing technology or similar methodologies. By eliminating this gene, the cell lines serve as an ideal platform for studying the downstream effects on synaptic vesicle dynamics and neuronal network function. Such investigations can deepen our understanding of conditions like autism spectrum disorders, epilepsy, and other neurodevelopmental diseases.
Scientifically, the importance of these cell lines lies in their ability to provide insights that can facilitate the discovery of novel therapeutic targets and strategies. In clinical research, RAB3GAP1 knockout models can assist in drug development processes by evaluating the efficacy of potential treatments aimed at restoring normal synaptic function.
Unique advantages of RAB3GAP1 Gene Knockout Cell Lines include their specificity and reproducibility, which surpass alternative methods that rely on chemical inhibition or transient gene silencing. These knockout models maintain stable genetic changes which allow for long-term studies and robust experimental design, making them invaluable for researchers seeking reliable results.
For researchers and clinicians invested in the realm of neurobiology and therapeutic innovations, investing in RAB3GAP1 Gene Knockout Cell Lines poses as a strategic advantage, enabling deeper insights and innovative discoveries in the area of neurotransmission and synaptic health.
Our company specializes in providing high-quality biological products tailored for cutting-edge research, ensuring that our customers have access to the latest tools needed to drive breakthroughs in their studies effectively.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.